 |
|||
   
  |
|
Active Portfolio Companies HCV has started leading biopharmaceutical companies in genetic therapy, genomic sciences, drug discovery and delivery, neuroscience, cancer therapy, and organ and cellular transplantation. This page includes a listing of the companies HCV currently works with, accompanied by a link to each company's website, if available. |
|
 |
|
Aciex |
 |
|
Anexon |
 |
|
Antisoma |
 |
|
Arresto BioSciences |
 |
|
Ascent Therapeutics |
 |
|
BIKAM Pharmaceuticals |
 |
|
BioProcessors |
 |
|
CardioKine |
 |
|
Catalyst Biosciences |
 |
|
Cornerstone Therapeutics |
 |
|
DecImmune Therapeutics |
 |
|
Dynogen Pharmaceuticals |
 |
|
FoldRx Pharmaceuticals |
 |
|
Galleon Pharmaceuticals |
 |
|
GenVec |
 |
|
GlobeImmune |
 |
|
InfaCare Pharmaceutical |
 |
|
MiddleBrook Pharmaceuticals |
 |
|
NitroMed |
 |
|
Oriel Therapeutics |
 |
|
Orqis Medical |
 |
|
PharmAthene |
 |
|
Potentia Pharmaceuticals |
 |
|
Progen Pharmaceuticals |
 |
|
Promedior |
 |
|
ProteoStasis Therapeutics |
 |
|
Radius Health |
 |
|
Replidyne |
 |
|
Sensors for Medicine and Science |
 |
|
Sequoia Pharmaceuticals |
 |
|
Shape Pharmaceuticals |
 |
Sierra Neuropharmaceuticals |
||
 |
|
SkinMedica |
 |
|
Spaltudaq |
 |
|
Starbridge Systems |
 |
Stemgent |
||
 |
|
Synovex |
 |
|
TetraLogic Pharmaceuticals |
 |
|
Threshold Pharmaceuticals |
 |
|
Tolerx |
 |
Trevena |
||
 |
|
U.S. Genomics |
 |
|
VaxInnate |
 |
|
Verenium |
 |
|
Visionary Therapeutics |
 |
|
Xanodyne Pharmaceuticals |
 |
|
Xencor |
 Nothing in this website constitutes an offer to sell, or a solicitation of an offer to buy, any securities.Rev 11/2008 ©1990-2008 HealthCare Ventures LLC |